Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

EU's Zero Tolerance on GM under fire

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

A recent draft Commission proposal to change the legislation governing genetically modified (GM) foods and feeds has revealed that the Commission is giving in to a long-standing combined demand from the biotech, food and animal feed industry to break down the so-called ‘zero-tolerance policy’ regarding contamination with non-authorised GM food and feed. This policy means that imported food and feed stuffs are not allowed to contain even the smallest amount of genetically modified material (referred to as genetically modified organisms or GMOs) that has not been approved for sale in the European Union.

This article examines evidence from the feed industry which shows how they distorted the facts and exaggerated the impacts as part of their lobby campaign to get rid of zero tolerance.

 

Read the full article here

 

Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
This must-watch film is now online. The film shows how corporations and actors within the Commission are teaming up to demolish a major piece of public health legislation.
Campaign groups today called on members of the European Parliament to back citizens' demands for improved rules to prohibit the cultivation of genetically modified (GM) crops. A letter signed by five environment, consumers and farmers groups was sent to all members of the parliament's environment committee, which will debate this controversial issue later in the week.
A few observations on the debate sparked by our open letter on the position of Chief Scientific Advisor to the President of the European Commission, and on the need for proper scientific advice to EU legislators.
A crusade for big business-friendly deregulation, waged during José Manuel Barroso's Presidency of the European Commission, shows no signs of stopping. This neoliberal push to weaken or block new legislation appears likely to expand with Jean-Claude Juncker's new Commission team.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.

Corporate Europe Forum